img

Global Migraine Treatment Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Migraine Treatment Medication Market Insights, Forecast to 2034

Migraine is a neurological condition that typically causes painful headache attacks that occur with additional symptoms, such as sensitivity to light, sound, smell, or touch. Migraine treatment medications aim to alleviate or prevent migraine headaches.
Market Analysis and InsightsGlobal Migraine Treatment Medication Market
Global Migraine Treatment Medication market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Migraine Treatment Medication industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Migraine Treatment Medication key companies include GSK, Pfizer, Novartis, Teva, Sun Pharma, Grünenthal, Endo Pharmaceuticals, Merck and Johnson & Johnson, etc. GSK, Pfizer, Novartis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Migraine Treatment Medication were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Migraine Treatment Medication market and estimated to attract more attentions from industry insiders and investors.
Migraine Treatment Medication can be divided into Triptans, NSAIDs and Others,, etc. Triptans is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Migraine Treatment Medication is widely used in various fields, such as Acute Migraine and Chronic Migraine, etc. Acute Migraine provides greatest supports to the Migraine Treatment Medication industry development. In 2022, global % revenue of Migraine Treatment Medication went into Acute Migraine filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Migraine Treatment Medication market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Migraine Treatment Medication market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
Pfizer
Novartis
Teva
Sun Pharma
Grünenthal
Endo Pharmaceuticals
Merck
Johnson & Johnson
AbbVie
Abbott
Bayer
Eli Lilly
Kowa Pharmaceuticals America
AstraZeneca
Segment by Type
Triptans
NSAIDs
Others

Segment by Application


Acute Migraine
Chronic Migraine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Migraine Treatment Medication introduction, etc. Migraine Treatment Medication Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Migraine Treatment Medication
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Treatment Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Migraine Treatment Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Acute Migraine
1.3.3 Chronic Migraine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Migraine Treatment Medication Market Perspective (2018-2033)
2.2 Global Migraine Treatment Medication Growth Trends by Region
2.2.1 Migraine Treatment Medication Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Migraine Treatment Medication Historic Market Size by Region (2018-2023)
2.2.3 Migraine Treatment Medication Forecasted Market Size by Region (2024-2033)
2.3 Migraine Treatment Medication Market Dynamics
2.3.1 Migraine Treatment Medication Industry Trends
2.3.2 Migraine Treatment Medication Market Drivers
2.3.3 Migraine Treatment Medication Market Challenges
2.3.4 Migraine Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Migraine Treatment Medication by Players
3.1.1 Global Migraine Treatment Medication Revenue by Players (2018-2023)
3.1.2 Global Migraine Treatment Medication Revenue Market Share by Players (2018-2023)
3.2 Global Migraine Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Migraine Treatment Medication, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Migraine Treatment Medication Market Concentration Ratio
3.4.1 Global Migraine Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Treatment Medication Revenue in 2022
3.5 Global Key Players of Migraine Treatment Medication Head office and Area Served
3.6 Global Key Players of Migraine Treatment Medication, Product and Application
3.7 Global Key Players of Migraine Treatment Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Treatment Medication Breakdown Data by Type
4.1 Global Migraine Treatment Medication Historic Market Size by Type (2018-2023)
4.2 Global Migraine Treatment Medication Forecasted Market Size by Type (2024-2033)
5 Migraine Treatment Medication Breakdown Data by Application
5.1 Global Migraine Treatment Medication Historic Market Size by Application (2018-2023)
5.2 Global Migraine Treatment Medication Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Migraine Treatment Medication Market Size (2018-2033)
6.2 North America Migraine Treatment Medication Market Size by Type
6.2.1 North America Migraine Treatment Medication Market Size by Type (2018-2023)
6.2.2 North America Migraine Treatment Medication Market Size by Type (2024-2033)
6.2.3 North America Migraine Treatment Medication Market Share by Type (2018-2033)
6.3 North America Migraine Treatment Medication Market Size by Application
6.3.1 North America Migraine Treatment Medication Market Size by Application (2018-2023)
6.3.2 North America Migraine Treatment Medication Market Size by Application (2024-2033)
6.3.3 North America Migraine Treatment Medication Market Share by Application (2018-2033)
6.4 North America Migraine Treatment Medication Market Size by Country
6.4.1 North America Migraine Treatment Medication Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Migraine Treatment Medication Market Size by Country (2018-2023)
6.4.3 North America Migraine Treatment Medication Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Migraine Treatment Medication Market Size (2018-2033)
7.2 Europe Migraine Treatment Medication Market Size by Type
7.2.1 Europe Migraine Treatment Medication Market Size by Type (2018-2023)
7.2.2 Europe Migraine Treatment Medication Market Size by Type (2024-2033)
7.2.3 Europe Migraine Treatment Medication Market Share by Type (2018-2033)
7.3 Europe Migraine Treatment Medication Market Size by Application
7.3.1 Europe Migraine Treatment Medication Market Size by Application (2018-2023)
7.3.2 Europe Migraine Treatment Medication Market Size by Application (2024-2033)
7.3.3 Europe Migraine Treatment Medication Market Share by Application (2018-2033)
7.4 Europe Migraine Treatment Medication Market Size by Country
7.4.1 Europe Migraine Treatment Medication Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Migraine Treatment Medication Market Size by Country (2018-2023)
7.4.3 Europe Migraine Treatment Medication Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Migraine Treatment Medication Market Size (2018-2033)
8.2 China Migraine Treatment Medication Market Size by Type
8.2.1 China Migraine Treatment Medication Market Size by Type (2018-2023)
8.2.2 China Migraine Treatment Medication Market Size by Type (2024-2033)
8.2.3 China Migraine Treatment Medication Market Share by Type (2018-2033)
8.3 China Migraine Treatment Medication Market Size by Application
8.3.1 China Migraine Treatment Medication Market Size by Application (2018-2023)
8.3.2 China Migraine Treatment Medication Market Size by Application (2024-2033)
8.3.3 China Migraine Treatment Medication Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Migraine Treatment Medication Market Size (2018-2033)
9.2 Asia Migraine Treatment Medication Market Size by Type
9.2.1 Asia Migraine Treatment Medication Market Size by Type (2018-2023)
9.2.2 Asia Migraine Treatment Medication Market Size by Type (2024-2033)
9.2.3 Asia Migraine Treatment Medication Market Share by Type (2018-2033)
9.3 Asia Migraine Treatment Medication Market Size by Application
9.3.1 Asia Migraine Treatment Medication Market Size by Application (2018-2023)
9.3.2 Asia Migraine Treatment Medication Market Size by Application (2024-2033)
9.3.3 Asia Migraine Treatment Medication Market Share by Application (2018-2033)
9.4 Asia Migraine Treatment Medication Market Size by Region
9.4.1 Asia Migraine Treatment Medication Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Migraine Treatment Medication Market Size by Region (2018-2023)
9.4.3 Asia Migraine Treatment Medication Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Migraine Treatment Medication Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Migraine Treatment Medication Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Migraine Treatment Medication Introduction
11.1.4 GSK Revenue in Migraine Treatment Medication Business (2018-2023)
11.1.5 GSK Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Migraine Treatment Medication Introduction
11.2.4 Pfizer Revenue in Migraine Treatment Medication Business (2018-2023)
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Migraine Treatment Medication Introduction
11.3.4 Novartis Revenue in Migraine Treatment Medication Business (2018-2023)
11.3.5 Novartis Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Migraine Treatment Medication Introduction
11.4.4 Teva Revenue in Migraine Treatment Medication Business (2018-2023)
11.4.5 Teva Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Company Details
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Migraine Treatment Medication Introduction
11.5.4 Sun Pharma Revenue in Migraine Treatment Medication Business (2018-2023)
11.5.5 Sun Pharma Recent Developments
11.6 Grünenthal
11.6.1 Grünenthal Company Details
11.6.2 Grünenthal Business Overview
11.6.3 Grünenthal Migraine Treatment Medication Introduction
11.6.4 Grünenthal Revenue in Migraine Treatment Medication Business (2018-2023)
11.6.5 Grünenthal Recent Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Details
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Migraine Treatment Medication Introduction
11.7.4 Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2018-2023)
11.7.5 Endo Pharmaceuticals Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Migraine Treatment Medication Introduction
11.8.4 Merck Revenue in Migraine Treatment Medication Business (2018-2023)
11.8.5 Merck Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Treatment Medication Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Treatment Medication Business (2018-2023)
11.9.5 Johnson & Johnson Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Migraine Treatment Medication Introduction
11.10.4 AbbVie Revenue in Migraine Treatment Medication Business (2018-2023)
11.10.5 AbbVie Recent Developments
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Migraine Treatment Medication Introduction
11.11.4 Abbott Revenue in Migraine Treatment Medication Business (2018-2023)
11.11.5 Abbott Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Migraine Treatment Medication Introduction
11.12.4 Bayer Revenue in Migraine Treatment Medication Business (2018-2023)
11.12.5 Bayer Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Migraine Treatment Medication Introduction
11.13.4 Eli Lilly Revenue in Migraine Treatment Medication Business (2018-2023)
11.13.5 Eli Lilly Recent Developments
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Company Details
11.14.2 Kowa Pharmaceuticals America Business Overview
11.14.3 Kowa Pharmaceuticals America Migraine Treatment Medication Introduction
11.14.4 Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2018-2023)
11.14.5 Kowa Pharmaceuticals America Recent Developments
11.15 AstraZeneca
11.15.1 AstraZeneca Company Details
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Migraine Treatment Medication Introduction
11.15.4 AstraZeneca Revenue in Migraine Treatment Medication Business (2018-2023)
11.15.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Migraine Treatment Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Triptans
Table 3. Key Players of NSAIDs
Table 4. Key Players of Others
Table 5. Global Migraine Treatment Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Migraine Treatment Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Migraine Treatment Medication Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Migraine Treatment Medication Market Share by Region (2018-2023)
Table 9. Global Migraine Treatment Medication Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Migraine Treatment Medication Market Share by Region (2024-2033)
Table 11. Migraine Treatment Medication Market Trends
Table 12. Migraine Treatment Medication Market Drivers
Table 13. Migraine Treatment Medication Market Challenges
Table 14. Migraine Treatment Medication Market Restraints
Table 15. Global Migraine Treatment Medication Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Migraine Treatment Medication Revenue Share by Players (2018-2023)
Table 17. Global Top Migraine Treatment Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2022)
Table 18. Global Migraine Treatment Medication Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Migraine Treatment Medication Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Migraine Treatment Medication, Headquarters and Area Served
Table 21. Global Key Players of Migraine Treatment Medication, Product and Application
Table 22. Global Key Players of Migraine Treatment Medication, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Migraine Treatment Medication Revenue Market Share by Type (2018-2023)
Table 26. Global Migraine Treatment Medication Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Migraine Treatment Medication Revenue Market Share by Type (2024-2033)
Table 28. Global Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Migraine Treatment Medication Revenue Share by Application (2018-2023)
Table 30. Global Migraine Treatment Medication Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Migraine Treatment Medication Revenue Share by Application (2024-2033)
Table 32. North America Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Migraine Treatment Medication Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Migraine Treatment Medication Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Migraine Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Migraine Treatment Medication Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Migraine Treatment Medication Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Migraine Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Migraine Treatment Medication Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Migraine Treatment Medication Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Migraine Treatment Medication Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Migraine Treatment Medication Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Migraine Treatment Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Migraine Treatment Medication Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Migraine Treatment Medication Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Migraine Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Migraine Treatment Medication Product
Table 67. GSK Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 68. GSK Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Migraine Treatment Medication Product
Table 72. Pfizer Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Migraine Treatment Medication Product
Table 77. Novartis Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Teva Company Details
Table 80. Teva Business Overview
Table 81. Teva Migraine Treatment Medication Product
Table 82. Teva Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 83. Teva Recent Developments
Table 84. Sun Pharma Company Details
Table 85. Sun Pharma Business Overview
Table 86. Sun Pharma Migraine Treatment Medication Product
Table 87. Sun Pharma Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 88. Sun Pharma Recent Developments
Table 89. Grünenthal Company Details
Table 90. Grünenthal Business Overview
Table 91. Grünenthal Migraine Treatment Medication Product
Table 92. Grünenthal Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 93. Grünenthal Recent Developments
Table 94. Endo Pharmaceuticals Company Details
Table 95. Endo Pharmaceuticals Business Overview
Table 96. Endo Pharmaceuticals Migraine Treatment Medication Product
Table 97. Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 98. Endo Pharmaceuticals Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Migraine Treatment Medication Product
Table 102. Merck Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Migraine Treatment Medication Product
Table 107. Johnson & Johnson Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 108. Johnson & Johnson Recent Developments
Table 109. AbbVie Company Details
Table 110. AbbVie Business Overview
Table 111. AbbVie Migraine Treatment Medication Product
Table 112. AbbVie Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 113. AbbVie Recent Developments
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Migraine Treatment Medication Product
Table 117. Abbott Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 118. Abbott Recent Developments
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Migraine Treatment Medication Product
Table 122. Bayer Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 123. Bayer Recent Developments
Table 124. Eli Lilly Company Details
Table 125. Eli Lilly Business Overview
Table 126. Eli Lilly Migraine Treatment Medication Product
Table 127. Eli Lilly Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 128. Eli Lilly Recent Developments
Table 129. Kowa Pharmaceuticals America Company Details
Table 130. Kowa Pharmaceuticals America Business Overview
Table 131. Kowa Pharmaceuticals America Migraine Treatment Medication Product
Table 132. Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 133. Kowa Pharmaceuticals America Recent Developments
Table 134. AstraZeneca Company Details
Table 135. AstraZeneca Business Overview
Table 136. AstraZeneca Migraine Treatment Medication Product
Table 137. AstraZeneca Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 138. AstraZeneca Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Treatment Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Migraine Treatment Medication Market Share by Type: 2022 VS 2033
Figure 3. Triptans Features
Figure 4. NSAIDs Features
Figure 5. Others Features
Figure 6. Global Migraine Treatment Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Migraine Treatment Medication Market Share by Application: 2022 VS 2033
Figure 8. Acute Migraine Case Studies
Figure 9. Chronic Migraine Case Studies
Figure 10. Migraine Treatment Medication Report Years Considered
Figure 11. Global Migraine Treatment Medication Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Migraine Treatment Medication Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Migraine Treatment Medication Market Share by Region: 2022 VS 2033
Figure 14. Global Migraine Treatment Medication Market Share by Players in 2022
Figure 15. Global Top Migraine Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Migraine Treatment Medication Revenue in 2022
Figure 17. North America Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Migraine Treatment Medication Market Share by Type (2018-2033)
Figure 19. North America Migraine Treatment Medication Market Share by Application (2018-2033)
Figure 20. North America Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 21. United States Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Migraine Treatment Medication Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Migraine Treatment Medication Market Share by Type (2018-2033)
Figure 25. Europe Migraine Treatment Medication Market Share by Application (2018-2033)
Figure 26. Europe Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 27. Germany Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Migraine Treatment Medication Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Migraine Treatment Medication Market Share by Type (2018-2033)
Figure 35. China Migraine Treatment Medication Market Share by Application (2018-2033)
Figure 36. Asia Migraine Treatment Medication Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Migraine Treatment Medication Market Share by Type (2018-2033)
Figure 38. Asia Migraine Treatment Medication Market Share by Application (2018-2033)
Figure 39. Asia Migraine Treatment Medication Market Share by Region (2018-2033)
Figure 40. Japan Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Migraine Treatment Medication Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Migraine Treatment Medication Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Migraine Treatment Medication Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 50. Brazil Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 59. Teva Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 60. Sun Pharma Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 61. Grünenthal Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 62. Endo Pharmaceuticals Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 63. Merck Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 64. Johnson & Johnson Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 65. AbbVie Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 66. Abbott Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 67. Bayer Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 68. Eli Lilly Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 69. Kowa Pharmaceuticals America Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 70. AstraZeneca Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries